Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
28.55
+0.47 (+1.67%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
44,208,493
Open
28.27
Bid (Size)
28.49 (300)
Ask (Size)
28.55 (1,300)
Prev. Close
28.08
Today's Range
28.04 - 28.64
52wk Range
20.91 - 28.64
Shares Outstanding
5,606,688,356
Dividend Yield
6.02%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Pfizer, BioNTech Hit Pause On COVID Shot Trial As Enrollment Falls Flat
↗
Today 13:56 EDT
Pfizer & BioNTech halt recruitment for a major U.S. COVID vaccine trial for adults 50–64 due to low enrollment. Read the latest updates.
Via
Benzinga
Oric Pharma Misses The 'Best-In-Class' Boat Vs. Pfizer — And Plunges
↗
Today 9:59 EDT
The company said its prostate cancer drug showed comparable effectiveness to a rival in the class.
Via
Investor's Business Daily
Performance
YTD
+13.4%
+13.4%
1 Month
+4.7%
+4.7%
3 Month
+14.7%
+14.7%
6 Month
+4.9%
+4.9%
1 Year
+16.3%
+16.3%
More News
Read More
Which S&P500 stocks are the most active on Tuesday?
↗
March 31, 2026
Via
Chartmill
Biotech Defies Gravity: Sarepta and Corcept Lead Midday Healthcare Rally Amidst Market Volatility
March 31, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
Stocks
Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability
March 31, 2026
Via
Finterra
Topics
Initial Public Offering
Prediction: Buying Pfizer Stock Today Could Set You Up for Life
↗
March 29, 2026
Via
The Motley Fool
Topics
Intellectual Property
1 Reason This Biotech Stock Could Triple Before Year-End
↗
March 29, 2026
Via
The Motley Fool
Is Now the Time to Buy Salesforce? Here's What the Numbers Reveal
↗
March 28, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Could Buying Eli Lilly Today Set You Up for Life?
↗
March 26, 2026
Via
The Motley Fool
Topics
Intellectual Property
Sarepta Therapeutics (SRPT) Stock Surges 34.98% on Breakthrough Clinical Data
March 26, 2026
Via
MarketMinute
Is Pfizer Stock a Buy After This Win?
↗
March 25, 2026
Via
The Motley Fool
The $6.7 Billion Pivot: A Deep Dive into Terns Pharmaceuticals (TERN) and the Merck Acquisition
March 25, 2026
Via
Finterra
Topics
Initial Public Offering
Intellectual Property
World Trade
Sarepta Therapeutics (SRPT) at a Crossroads: A 2026 Deep Dive into the Future of Genetic Medicine
March 25, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Retirement
Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience
March 25, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
Stay informed about the most active stocks in the S&P500 index on Tuesday's session.
↗
March 24, 2026
Via
Chartmill
Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts
March 24, 2026
From
Pfizer Inc.
Via
Business Wire
Pfizer To Rally More Than 34%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
March 24, 2026
Via
Benzinga
Bristol-Myers Squibb Shares Jump 3.3% on Robust 2026 Guidance and High Dividend Yield
March 23, 2026
Via
MarketMinute
Topics
Economy
Initial Public Offering
Intellectual Property
Pfizer Stock Is Doing Something It Hasn't Done Since 2022
↗
March 23, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
5 High-Yield Stocks to Shield Your Portfolio From the Storm
↗
March 23, 2026
Via
MarketBeat
Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive
↗
March 23, 2026
Via
Benzinga
Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
March 23, 2026
Via
Benzinga
Topics
Stocks
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
March 23, 2026
From
Pfizer Inc.
Via
Business Wire
Have $500? 2 Healthcare Stocks Long-Term Investors Should Buy Right Now
↗
March 23, 2026
Via
The Motley Fool
Topics
Intellectual Property
2 Unpopular Stocks That Should Get More Attention and 1 We Avoid
March 23, 2026
Via
StockStory
Topics
Supply Chain
Frequently Asked Questions
Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 28.55
When was Pfizer last traded?
The last trade of Pfizer was at 04/01/26 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 160.07B
How many shares of Pfizer are outstanding?
Pfizer has 160B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.